Navigation Links
Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!'s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenner's New Face
Date:5/18/2009

BEVERLY HILLS, Calif., May 18 /PRNewswire/ -- After teasing viewers with the news that a member of the Kardashian family will undergo plastic surgery this season, the latest episode of E!'s hit reality show Keeping up with the Kardashians has revealed the secrets behind former Olympian and Kardashian stepfather Bruce Jenner's "new face." After undergoing ill-advised plastic surgery 25 years ago, celebrity plastic surgeon Dr. Garth Fisher is the miracle worker who corrected Jenner's facelift -- and regularly consults with the Kardashian clan to ensure that their skin is ready for High Definition TV screens at all times.

"Unfortunately Bruce has been the brunt of jokes regarding plastic surgery he had 25 years ago. Sadly it could not have happened to a nicer and more decent human being," says Dr. Fisher. "Aside from being able to substantiate the claim of the world's greatest athlete, he is a very intelligent and successful businessman, and amazing father and family member. I am delighted that I was able to utilize more modern facial rejuvenating techniques to undo some of the challenging previous work and recontour his face in a more natural way. I am pleased with the results, and as a close friend of the wonderful Kardashian family, I was thrilled to help restore Bruce's natural good looks."

Dr. Fisher recommends that Jenner -- and anyone who is concerned with maintaining youthful skin without drastic surgery -- use CellCeuticals(R) Biomedical Skin Treatments. CellCeuticals is a revolutionary new system that integrates the latest advances in biotechnology and medical science into bio-treatments that target the underlying source of cellular skin aging and help re-create visibly younger skin.

The Kardashian family has been using CellCeuticals products since the line launched in January 2009 for the quick, effective results. Reality star and Hollywood fixture Kim Kardashian has raved, "I am in lov
'/>"/>

SOURCE CellCeuticals(R) Biomedical Skin Treatments
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Kim Kardashian and Tia Carrere Celebrate Premiere of Revolutionary CellCeuticals(R) Biomedical Skin Treatments at Social Hollywood with Founders Dr. Garth Fisher and Paul Scott Premo
2. Dr. Garth Gemar, M.D. Named Medical Director of Southwest Ambulance
3. Garth Brooks, Jon McLaughlin, and Pat Benatar and Neil Giraldo Raise Their Voices to Help Starkey Hearing Foundation Raise More Than $5 Million at Annual Fundraiser
4. Rehab Specialist, Michael Fisher, Joins Fast - Growing Alliance Seating & Mobility in North Carolina
5. TotSpot.com Celebrates Launch With Jenny McCarthy, Joely Fisher, Tori Spelling and Other Celebrity Mommies at The Treehouse Social Club
6. Martin Crane, M.D., Assumes Chairmanship of the Federation of State Medical Boards
7. Vivek Y. Reddy, M.D., Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories
8. Joseph C. Kolars, M.D., to be U-M Medical Schools First Senior Associate Dean for Education and Global Initiatives
9. Dr. Siegal's Cookie Diet Book by Sanford Siegal, D.O., M.D., Available May 22nd
10. Richard E. Smith, M.D., Installed as President of Michigan State Medical Society
11. Dr. Siegals Cookie Diet Book by Physician, Author, and Weight-Loss Expert Sanford Siegal, D.O., M.D., Available May 22nd
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 1Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 2Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 1Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 2Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 3Nostrils Compete to Relay Key Fragrance 54963 1Nostrils Compete to Relay Key Fragrance 54963 2